Structurally divided into upper and lower respiratory systems and functionally divided into conducting and respiratory zones.
2
New cards
Conducting zone
Part of the respiratory system that carries air from outside the body toward the lungs; includes the nasal cavity, pharynx, larynx, trachea, bronchi, bronchioles, and terminal bronchioles.
3
New cards
Respiratory zone
Part of the respiratory system where oxygen and carbon dioxide are exchanged; includes respiratory bronchioles, alveolar ducts, alveolar sacs, and alveoli.
4
New cards
Alveoli
Air sacs in the lungs where oxygen and carbon dioxide are exchanged between air and blood; surrounded by pulmonary capillaries.
5
New cards
Type I alveolar cells
Alveolar cells that form the thin surface involved in gas exchange.
6
New cards
Type II alveolar cells
Alveolar cells involved in producing surfactant.
7
New cards
Ventilation
Movement of air into and out of the lungs.
8
New cards
Alveolar ventilation
Volume of air entering the alveoli each minute that participates in oxygen and carbon dioxide exchange.
9
New cards
Respiratory membrane
Membrane between alveolar air and capillary blood composed of alveolar cells, basement membranes, and capillary endothelium.
10
New cards
Lung compliance
Ability of the lungs to expand in response to changes in pressure; describes how easily the lungs inflate.
11
New cards
Elastic recoil
Natural tendency of lung tissue to recoil inward after expansion.
12
New cards
Surfactant
Substance that reduces alveolar surface tension, prevents alveolar collapse during expiration, increases lung compliance, and decreases work of breathing.
13
New cards
Tidal volume (TV)
Amount of air moved into and out of the lungs with each normal breath; approximately 500 mL.
14
New cards
Vital capacity (VC)
Maximum volume of air a person can forcefully exhale after maximum inhalation.
15
New cards
Residual volume (RV)
Amount of air remaining in the lungs after expiration; helps keep alveoli open.
16
New cards
Total lung capacity (TLC)
Maximum volume of air the lungs can hold; TLC = VC + RV; approximately 6000 mL.
17
New cards
Central chemoreceptors
Chemoreceptors located in the medulla oblongata that respond primarily to increased CO2 through increased hydrogen ions and decreased CSF pH.
18
New cards
Peripheral chemoreceptors
Chemoreceptors located in the carotid and aortic bodies that respond to hypoxemia and stimulate increased ventilation.
19
New cards
Hypercapnia
Increased carbon dioxide levels in the blood.
20
New cards
Hypoxemia
Marked decrease in oxygen levels in arterial blood.
21
New cards
Hypercapnia and central chemoreceptors
CO2 diffuses into cerebrospinal fluid, lowers pH, stimulates central chemoreceptors, and increases respiratory rate and depth.
22
New cards
Hypoxic drive
Respiratory regulation that relies more heavily on low arterial oxygen levels to stimulate breathing.
23
New cards
Hypercapnic desensitization
Chronic hypercapnia causes central chemoreceptors to become less sensitive to elevated carbon dioxide.
24
New cards
PaO2 threshold associated with hypoxic drive
PaO2 below 60 mmHg stimulates peripheral chemoreceptors in the hypoxic-drive mechanism described in the presentation.
25
New cards
Mild hypoxemia manifestations
Increased heart rate, peripheral vasoconstriction, diaphoresis, and increased blood pressure.
26
New cards
Chronic hypoxemia manifestations
Increased ventilation, increased erythropoietin and red blood cell production, and cyanosis.
27
New cards
Erythropoietin (EPO)
Hormone released in response to hypoxia that stimulates red blood cell production.
28
New cards
Eupnea
Normal breathing pattern; approximately 14–20 breaths per minute according to the presentation.
29
New cards
Tachypnea
Abnormally rapid breathing.
30
New cards
Bradypnea
Abnormally slow breathing.
31
New cards
Apnea
Cessation of breathing.
32
New cards
Kussmaul respirations
Slightly increased respiratory rate with very large tidal volumes and no expiratory pause; commonly associated with diabetic ketoacidosis.
33
New cards
Cheyne-Stokes respiration
Cyclic breathing pattern alternating between deeper, faster breathing and shallower breathing, followed by apnea; associated with heart failure and neurologic conditions.
34
New cards
Dyspnea
Subjective sensation of uncomfortable breathing or shortness of breath.
35
New cards
Severe dyspnea
Shortness of breath accompanied by nasal flaring and use of accessory respiratory muscles.
36
New cards
Dyspnea on exertion
Shortness of breath occurring during physical activity.
37
New cards
Orthopnea
Difficulty breathing when lying down.
38
New cards
Wheezing
High-pitched whistling sound produced when air passes through narrowed airways.
39
New cards
Hemoptysis
Coughing up blood.
40
New cards
Productive cough
Cough that produces mucus or sputum.
41
New cards
Nonproductive cough
Dry cough that does not produce mucus or sputum.
42
New cards
Abnormal sputum
Changes in sputum amount, consistency, color, and odor that provide information about disease progression and treatment effectiveness.
43
New cards
Pneumothorax
Accumulation of air in the pleural cavity causing partial or complete lung collapse.
44
New cards
Pneumothorax manifestations
Chest pain, dyspnea, tachypnea, and reduced breath sounds.
45
New cards
Closed pneumothorax
Pneumothorax in which air enters the pleural cavity from internal airways.
46
New cards
Secondary pneumothorax
Pneumothorax associated with underlying respiratory disease, such as rupture of an emphysematous bleb or tumor erosion.
47
New cards
Open pneumothorax
Traumatic pneumothorax in which atmospheric air enters the pleural cavity through an opening in the chest wall.
48
New cards
Tension pneumothorax
Air enters the pleural cavity during inhalation but cannot escape during exhalation, causing progressive pressure buildup; the most serious pneumothorax type.
49
New cards
Pleural effusion
Excessive fluid accumulation in the pleural cavity that increases pressure within the pleural space.
50
New cards
Exudative pleural effusion
Inflammation-related pleural fluid that may contain purulent drainage or blood.
51
New cards
Transudative pleural effusion
Watery pleural fluid caused by increased hydrostatic pressure or decreased blood vessel osmotic pressure.
52
New cards
Pleural effusion manifestations
Localized lower or lateral chest pain, pain worsening with movement, dullness to percussion, absent breath sounds over the affected area, and dry cough.
53
New cards
Thoracocentesis
Procedure used to remove fluid from the pleural cavity.
54
New cards
Atelectasis
Incomplete expansion or collapse of an entire lung or part of a lung, resulting in decreased gas exchange and hypoxia.
55
New cards
Atelectasis and pulmonary vasoconstriction
When alveoli receive little or no oxygen, nearby pulmonary blood vessels constrict.
56
New cards
Obstructive atelectasis
Collapse of lung tissue caused by total obstruction of an airway.
57
New cards
Compression atelectasis
Collapse caused by an external mass or tumor exerting pressure on part of the lung.
58
New cards
Postoperative atelectasis
Atelectasis occurring after surgery.
59
New cards
COPD
Chronic respiratory disorders characterized by irreversible, progressive lung damage, long-term breathing difficulties, and airflow limitation.
60
New cards
COPD risk factors
Tobacco smoke, secondhand smoke, air pollution, chemical fumes, dust, and alpha-1 antitrypsin deficiency.
61
New cards
Cor pulmonale
Right-sided heart failure associated with pulmonary disease and pulmonary hypertension.
62
New cards
Bronchial smooth muscle
Found in bronchi and bronchioles; controls airway diameter and regulates airflow.
63
New cards
Parasympathetic vagal stimulation
Promotes bronchoconstriction through bronchial smooth muscle.
64
New cards
Sympathetic beta-2 adrenergic stimulation
Promotes bronchodilation and relaxation of bronchial smooth muscle.
65
New cards
Asthma
Chronic disorder characterized by hypersensitive or hyperresponsive airways and bronchial obstruction.
66
New cards
Extrinsic asthma
Asthma triggered by type I hypersensitivity reactions.
67
New cards
Intrinsic asthma
Asthma triggered by factors such as cold, respiratory infections, and stress.
68
New cards
Asthma pathologic changes
Mucosal inflammation and edema, bronchoconstriction, and increased secretion of thick mucus.
69
New cards
Early-phase asthma response
Bronchoconstriction from smooth muscle contraction, increased mucus secretion, and attraction of other immune cells.
70
New cards
Late-phase asthma response
Occurs approximately 4–24 hours after the initial response and involves eosinophil recruitment and sustained inflammation.
71
New cards
Asthma and expiration
Expiration becomes prolonged because narrowed airways obstruct airflow; accessory expiratory muscles may be used.
72
New cards
Asthma and lung volumes
Forced expiratory volume decreases and residual volume increases because of air trapping.
73
New cards
Asthma wheezing
Air forced through narrowed airways creates a high-pitched whistling sound, especially during expiration.
74
New cards
Early asthma acid-base change
Mild respiratory alkalosis caused by hyperventilation.
75
New cards
Prolonged severe asthma acid-base change
Respiratory acidosis caused by airway obstruction and air trapping.
76
New cards
Status asthmaticus
Severe asthma attack that does not respond to usual therapy and may be fatal because of severe hypoxia and acidosis.
77
New cards
Peak expiratory flow rate
Measurement used to assess and monitor asthma.
78
New cards
Albuterol
Short-acting beta-2 agonist that relaxes bronchial smooth muscle and promotes bronchodilation.
79
New cards
Asthma treatment
Beta-2 agonists, including short- and long-acting medications, and corticosteroids.
80
New cards
Emphysema
Abnormal permanent enlargement of air spaces distal to terminal bronchioles with destruction of alveolar walls and septa.
81
New cards
Emphysema alveolar changes
Destruction of alveolar walls creates large permanently inflated air spaces and decreases surface area for gas exchange.
82
New cards
Emphysema and pulmonary capillaries
Destruction of alveolar walls leads to loss of pulmonary capillaries and altered ventilation-perfusion matching.
83
New cards
Alpha-1 antitrypsin (AAT)
Protein produced mainly by the liver that protects lung tissue from neutrophil elastase.
84
New cards
Neutrophil elastase
Enzyme released by neutrophils that breaks down bacteria and can damage elastic fibers in the lungs.
85
New cards
Alpha-1 antitrypsin deficiency
Genetic deficiency that allows uninhibited elastase to destroy lung elastic fibers, contributing to early-onset emphysema.
86
New cards
Emphysema air trapping
Progressive difficulty with expiration causes air trapping, increased residual volume, and lung overinflation.
87
New cards
Barrel chest
Increased anterior-posterior thoracic diameter caused by fixation of ribs in a respiratory position.
88
New cards
Flattened diaphragm
Structural manifestation of emphysema visible on radiographs.
89
New cards
Pink puffer
Traditional emphysema description characterized by shortness of breath and pink skin, with cyanosis occurring later.
90
New cards
Pursed-lip breathing
Breathing technique associated with emphysema.
91
New cards
Emphysema treatment
Alpha-1 antitrypsin replacement injections, anti-inflammatory drugs, bronchodilators, oxygen therapy as disease advances, and late-stage interventions.
92
New cards
Chronic bronchitis
Inflammation, obstruction, and repeated infection of bronchi with excessive mucus production, persistent cough, and difficulty breathing.
93
New cards
Clinical definition of chronic bronchitis
Productive cough lasting at least 3 months per year for 2 consecutive years after excluding other causes.
94
New cards
Chronic bronchitis risk factors
Cigarette smoking, urban or industrial exposure, and chronic irritation from smoke.
95
New cards
Chronic bronchitis large-airway changes
Increased goblet cells and squamous metaplasia of ciliated epithelial cells, impairing ciliary function and promoting mucus plugs.
96
New cards
Chronic bronchitis small-airway changes
Smooth muscle hyperplasia and fibrosis thicken airway walls and narrow bronchial lumens.
97
New cards
Chronic bronchitis manifestations
Gradual development of productive cough, followed by dyspnea and wheezing in advanced stages.
98
New cards
Blue bloater
Traditional chronic bronchitis description associated with cyanosis and fluid retention from right-sided heart failure.
99
New cards
Chronic bronchitis and cor pulmonale
Pulmonary capillary fibrosis causes pulmonary hypertension, which can lead to right-sided heart failure and peripheral edema.
100
New cards
Bronchiectasis
Abnormal irreversible dilation of medium-sized bronchi caused by weakening and permanent damage to bronchial muscle and elastic fibers.